| Year |
Citation |
Score |
| 2018 |
Wagener JS, Williams MJ, Millar SJ, Morgan WJ, Pasta DJ, Konstan MW. Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 29685810 DOI: 10.1016/j.jcf.2018.02.003 |
0.306 |
|
| 2016 |
McKone E, Sawicki G, Millar S, Pasta D, Rubin J, Konstan M, Wagener J. ePS03.4 Improved rate of decline in percent predicted FEV 1 (ppFEV 1 ) is not associated with acute improvement in ppFEV 1 in patients with cystic fibrosis (CF) treated with ivacaftor Journal of Cystic Fibrosis. 15: S42. DOI: 10.1016/S1569-1993(16)30208-9 |
0.338 |
|
| 2015 |
Rubin-Cahill J, Thayer S, Watkins A, Wagener J, Hodgkins P, Schechter M. 191 Lung function and health care resource utilization in patients with cystic fibrosis Journal of Cystic Fibrosis. 14: S107. DOI: 10.1016/S1569-1993(15)30368-4 |
0.354 |
|
| 2015 |
Rubin-Cahill J, Thayer S, Watkins A, Wagener J, Hodgkins P, Schechter M. 190 Frequency and costs of pulmonary exacerbations and association with % predicted FEV 1 in patients with cystic fibrosis Journal of Cystic Fibrosis. 14: S106. DOI: 10.1016/S1569-1993(15)30367-2 |
0.302 |
|
| 2014 |
Sawicki G, McKone E, Pasta D, Wagener J, Johnson C, Konstan M. WS3.1 The effect of ivacaftor on the rate of lung function decline in CF patients with a G551D-CFTR mutation Journal of Cystic Fibrosis. 13: S6. DOI: 10.1016/S1569-1993(14)60019-9 |
0.33 |
|
| 2009 |
Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, Ramsey BW. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. The Journal of Pediatrics. 154: 183-8. PMID 18822427 DOI: 10.1016/J.Jpeds.2008.08.001 |
0.304 |
|
| Show low-probability matches. |
